BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 27743850)

  • 1. Current beliefs and practice patterns among urologists regarding prostate magnetic resonance imaging and magnetic resonance-targeted biopsy.
    Muthigi A; Sidana A; George AK; Kongnyuy M; Maruf M; Valayil S; Wood BJ; Pinto PA
    Urol Oncol; 2017 Jan; 35(1):32.e1-32.e7. PubMed ID: 27743850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyzing the current practice patterns and views among urologists regarding focal therapy for prostate cancer.
    Jain AL; Sidana A; Maruf M; Sugano D; Calio B; Wood BJ; Pinto PA
    Urol Oncol; 2019 Mar; 37(3):182.e1-182.e8. PubMed ID: 30522903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Role of Multiparametric MRI and MRI Targeted Biopsies for Prostate Cancer Diagnosis in Germany: A Nationwide Survey.
    Saar M; Linxweiler J; Borkowetz A; Fussek S; Urbanova K; Bellut L; Kristiansen G; Wullich B;
    Urol Int; 2020; 104(9-10):731-740. PubMed ID: 32640460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate MRI: a national survey of Urologist's attitudes and perceptions.
    Manley BJ; Brockman JA; Raup VT; Fowler KJ; Andriole GL
    Int Braz J Urol; 2016; 42(3):464-71. PubMed ID: 27286108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current practice and access to prostate MR imaging in France.
    Renard-Penna R; Rouvière O; Puech P; Borgogno C; Abbas L; Roy C; Claudon M; Correas JM; Cormier L; Ploussard G; Mejean A; Tezenas-du-Montcel S; Rozet F
    Diagn Interv Imaging; 2016 Nov; 97(11):1125-1129. PubMed ID: 27451262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptions of Prostate MRI and Fusion Biopsy of Radiation Oncologists and Urologists for Patients Diagnosed with Prostate Cancer: Results from a National Survey.
    Bukavina L; Tilburt JC; Konety B; Shah ND; Gross CP; Yu JB; Schumacher F; Kutikov A; Smaldone MC; Kim SP
    Eur Urol Focus; 2020 Mar; 6(2):273-279. PubMed ID: 30219709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients?
    Rubin MA; Bismar TA; Curtis S; Montie JE
    Am J Surg Pathol; 2004 Jul; 28(7):946-52. PubMed ID: 15223967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge, attitudes and beliefs towards management of men with locally advanced prostate cancer following radical prostatectomy: an Australian survey of urologists.
    Brown B; Young J; Kneebone AB; Brooks AJ; Dominello A; Haines M
    BJU Int; 2016 Apr; 117 Suppl 4():35-44. PubMed ID: 25585989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.
    Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS
    Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial.
    Wysock JS; Rosenkrantz AB; Huang WC; Stifelman MD; Lepor H; Deng FM; Melamed J; Taneja SS
    Eur Urol; 2014 Aug; 66(2):343-51. PubMed ID: 24262102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens.
    Steurer S; Rico SD; Simon R; Minner S; Tsourlakis MC; Krech T; Koop C; Graefen M; Heinzer H; Adam M; Huland H; Schlomm T; Sauter G; Lumiani A
    BJU Int; 2017 Sep; 120(3):365-376. PubMed ID: 28295933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
    Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
    J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric ultrasound-targeted biopsy compares favorably to multiparametric MRI-transrectal ultrasound fusion-targeted biopsy on initial biopsy of men at risk for prostate cancer.
    Fulgham PF
    World J Urol; 2018 May; 36(5):713-718. PubMed ID: 29368230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryosurgery, an alternative treatment option for organ-confined prostate cancer: current beliefs and practice patterns of urologists.
    Kongnyuy M; Halpern DM; Kosinski KE; Katz AE
    Int Urol Nephrol; 2017 Jan; 49(1):43-48. PubMed ID: 27761695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 3: Targeted Biopsy.
    Venderink W; Bomers JG; Overduin CG; Padhani AR; de Lauw GR; Sedelaar MJ; Barentsz JO
    Eur Urol; 2020 Apr; 77(4):481-490. PubMed ID: 31791623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?
    Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F
    J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted prostate biopsy and MR-guided therapy for prostate cancer.
    Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
    Abdom Radiol (NY); 2016 May; 41(5):877-88. PubMed ID: 26907717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen.
    Lian H; Zhuang J; Wang W; Zhang B; Shi J; Li D; Fu Y; Jiang X; Zhou W; Guo H
    BMC Urol; 2017 Jul; 17(1):52. PubMed ID: 28679370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.
    Alberts AR; Schoots IG; Bokhorst LP; van Leenders GJ; Bangma CH; Roobol MJ
    Eur Urol; 2016 Jun; 69(6):1129-34. PubMed ID: 26651990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.
    Meng X; Rosenkrantz AB; Mendhiratta N; Fenstermaker M; Huang R; Wysock JS; Bjurlin MA; Marshall S; Deng FM; Zhou M; Melamed J; Huang WC; Lepor H; Taneja SS
    Eur Urol; 2016 Mar; 69(3):512-7. PubMed ID: 26112001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.